Proto Labs, Inc.

PRLB Industrials Metal Fabrication

Proto Labs, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $533.1 million, up 6.44% from fiscal 2024. In the quarter to June 2026, revenue grew 10.6%, EPS grew 100.0% and free cash flow grew 1.35%, each against the same quarter a year earlier.

85.65 1.76 −2.01%
Market cap
$2.1B
P/E
67.4×
Fwd P/E
55.0×
Dividend yield
—
F-score
7/9
Altman Z
9.63
Beneish M
−2.75
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
56.84 59.23 57.11 0.00 42.44 80.74 42.67 39.86 53.26 32.59
Piotroski F-Score
7 8 8 3 4 5 5 7 6 5
Altman Z-Score
9.63 9.47 9.42 4.85 9.90 26.49 20.71 25.73 30.64 25.81
P/S ratio
2.27 1.96 1.97 1.42 2.91 9.44 5.95 6.83 8.03 4.67
P/FCF ratio
20.01 14.28 21.70 15.58 67.43 68.41 50.69 84.95 56.35 31.72
Altman Z″-Score (non-manufacturers)
10.59 12.09 12.08 8.18 11.21 10.60 11.21 11.56 12.30 16.11
Beneish M-Score
(2.75) (2.97) (2.81) (3.67) (1.90) (2.70) (2.95) (2.68) (2.34) (2.92)
P/Operating CF
73.57 56.73 57.76 65.95 61.61 166.77 84.54 80.16 121.65 71.92
P/B ratio
1.80 1.46 1.43 0.99 1.71 6.37 4.66 5.62 6.00 3.67
Price to Tangible BV
3.17 2.62 2.51 1.77 3.64 8.18 6.21 7.75 8.82 4.00
EV/Sales
2.04 1.76 1.78 1.27 2.76 9.09 5.63 6.55 7.77 4.31
EV/EBITDA
18.45 15.85 13.67 0.00 16.66 42.70 23.31 25.14 29.19 15.96
EV/Operating CF
14.59 11.35 12.25 10.00 24.38 36.90 22.24 23.73 32.76 16.57
EV/FCF
17.97 12.86 19.58 13.95 64.04 65.82 47.96 81.41 54.53 29.26
Quick Ratio
3.13 3.24 3.58 2.24 2.89 4.38 4.58 3.73 3.37 6.09
Current Ratio
3.49 3.66 4.04 2.61 3.34 4.82 4.97 4.08 3.77 6.74
Net Debt/EBITDA
(2.17) (1.84) (1.56) 1.33 (0.94) (1.73) (1.37) (1.14) (0.97) (1.35)
Debt/Assets
0.00% 0.04% 0.08% 0.28% 0.15% 0.26% 1.27% 0.00% 0.96% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00
Asset Turnover
0.71 0.66 0.64 0.56 0.58 0.61 0.71 0.78 0.74 0.77
Operating CF/Net income
3.51 4.69 4.26 (0.60) 1.66 2.10 1.82 1.61 1.58 1.81
Capex/Depreciation
(0.41) (0.26) (0.73) (0.45) (0.84) (1.44) (2.02) (3.21) (1.67) (1.80)
ROE
3.16% 2.43% 2.47% (13.56%) 4.53% 8.27% 11.29% 15.28% 12.31% 12.07%
ROA
2.82% 2.19% 2.19% (11.96%) 3.99% 7.18% 9.85% 13.46% 11.10% 11.02%
ROIC
2.88% 2.19% 2.97% (9.88%) 3.35% 7.72% 11.51% 13.56% 12.13% 14.22%
Return on Tangible Assets
5.56% 4.50% 4.26% (27.75%) 8.16% 10.72% 14.07% 19.61% 18.00% 15.60%
Average Days of Receivables
55.75 50.58 54.38 59.99 60.85 49.08 45.71 53.17 56.51 42.26
Research and Development Expense of Revenue
8.03% 8.24% 7.97% 7.83% 9.06% 8.50% 7.13% 6.45% 6.84% 7.51%
Selling, General and Administrative Expense of Revenue
31.54% 31.23% 30.46% 30.77% 28.30% 27.87% 26.76% 27.16% 28.46% 27.77%
Intangible Assets out of Total Assets
0.38 0.40 0.39 0.38 0.47 0.19 0.22 0.24 0.28 0.08
Share Based Compensation of Revenue
2.95% 3.39% 3.17% 3.59% 3.91% 3.38% 2.35% 2.45% 2.48% 0.00%
Graham Net Nets
0.12 0.12 0.12 0.12 0.06 0.03 0.05 0.05 0.04 0.09
Graham Number
23.75 19.91 19.94 0.00 28.58 32.10 34.17 35.75 27.56 22.92
Earnings Yield
1.76% 1.69% 1.75% (15.10%) 2.36% 1.24% 2.34% 2.51% 1.88% 3.07%
Free Cash Flow Yield
5.00% 7.00% 4.61% 6.42% 1.48% 1.46% 1.97% 1.18% 1.77% 3.15%
Revenue per Share
22.29 19.96 19.24 17.82 17.67 16.25 17.07 16.51 12.93 11.30
Operating CF per Share
3.11 3.10 2.80 2.26 2.00 4.00 4.32 4.56 3.07 2.94
Capex per Share
(0.59) (0.36) (1.05) (0.64) (1.24) (1.76) (2.32) (3.23) (1.22) (1.27)
Free Cash Flow per Share
2.53 2.74 1.75 1.62 0.76 2.24 2.00 1.33 1.84 1.66
Cash per Share
5.36 4.11 3.93 2.92 2.81 6.05 5.98 4.88 3.53 4.11
Shareholders Equity per Share
28.17 26.70 26.55 25.45 30.00 24.10 21.80 20.07 17.31 14.41
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
28.17 26.70 26.55 25.45 30.00 24.10 21.80 20.07 17.31 14.41
Free Cash Flow
60.50 68.69 45.86 44.50 21.03 59.96 53.82 35.83 49.11 43.88
Working Capital
166.54 141.58 150.98 114.99 128.60 191.75 188.84 162.63 121.25 134.36
Capital Expenditures
(14.01) (9.13) (27.42) (17.58) (34.21) (47.01) (62.23) (87.10) (32.63) (33.62)
Net Current Asset Value
144.06 121.49 123.60 82.05 83.40 142.15 148.54 137.87 107.48 123.38
EV/EBIT
43.30 44.36 31.88 0.00 33.39 65.96 32.32 32.81 37.08 20.79
Capex to Sales
0.03 0.02 0.05 0.04 0.07 0.11 0.14 0.20 0.09 0.11
Price to Operating Income
48.20 49.27 35.33 0.00 35.15 68.55 34.17 34.23 38.32 22.54
Other line items
Depreciation/Fixed assets
0.16 0.16 0.15 0.15 0.14 0.12 0.12 0.12 0.12 0.13
Cash ROIC
7.54% 8.88% 5.74% 5.71% 2.32% 7.42% 7.13% 5.32% 8.76% 8.99%
Accounts Receivable Turnover
7.07 6.93 6.49 6.04 6.98 7.50 7.50 7.54 7.84 7.78
Accounts Payable Turnover
19.34 17.83 17.09 12.78 12.17 12.36 13.06 12.43 11.08 10.50
Inventory Turnover
22.17 21.39 20.70 20.41 22.10 20.69 22.16 19.38 14.64 13.74
Average Days of Payables
18.63 20.38 20.25 23.21 34.88 30.75 27.45 30.71 38.47 31.52
Days of Inventory on Hand
17.76 16.17 17.68 18.16 18.10 18.31 16.46 17.79 27.31 25.92
Average Receivables
75.42 72.24 77.67 80.82 69.89 57.93 61.18 59.12 43.92 38.33
Average Payables
15.30 15.57 16.50 21.36 21.81 17.53 17.11 16.64 13.60 12.48
Average Inventory
13.35 12.98 13.62 13.37 12.01 10.47 10.08 10.68 10.29 9.54
Average Assets
753.46 757.93 787.26 865.38 836.39 708.94 646.33 568.86 466.49 387.64
Average Common Equity
672.04 682.72 696.47 763.07 736.42 615.07 563.64 501.36 420.52 353.74

Fold the line items

Columns are period end dates